Shares Outstanding: 112.00M
The shares outstanding is 112.00M. It is below its 12-month average by 0.53% (112.60M).
DGX Shares Outstanding
Reported quarterly weighted average share count; no daily interpolation.
DGX Average Shares Outstanding Chart
DGX Current vs Average Shares Outstanding Chart
DGX Shares Outstanding Metrics
SHARES OUTSTANDING
112.00M
SHARES OUTSTANDING AVG TTM
112.60M
SHARES OUTSTANDING AVG 3Y
112.85M
SHARES OUTSTANDING AVG 5Y
115.85M
SHARES OUTSTANDING AVG 10Y
127.44M
SHARES OUTSTANDING AVG 15Y
135.68M
SHARES OUTSTANDING AVG 20Y
149.06M
CURRENT VS TTM AVG
-0.53%
CURRENT VS 3Y AVG
-0.75%
CURRENT VS 5Y AVG
-3.32%
CURRENT VS 10Y AVG
-12.11%
CURRENT VS 15Y AVG
-17.45%
CURRENT VS 20Y AVG
-24.86%
Share Structure
Shares Outstanding
111.00M
Float Shares
N/A
Stock Price
$206.24
Market Cap
$22.8B
Quarterly Shares Outstanding History
| Period | Weighted Average Shares | QoQ Change |
|---|---|---|
| Q1 2026 | 112.00M | +0.00% |
| Q4 2025 | 112.00M | -0.88% |
| Q3 2025 | 113.00M | +0.00% |
| Q2 2025 | 113.00M | +0.00% |
| Q1 2025 | 113.00M | +0.00% |
| Q4 2024 | 113.00M | +0.00% |
| Q3 2024 | 113.00M | +0.89% |
| Q2 2024 | 112.00M | +0.00% |
| Q1 2024 | 112.00M | -0.88% |
| Q4 2023 | 113.00M | -0.88% |
| Q3 2023 | 114.00M | +0.00% |
| Q2 2023 | 114.00M | +0.88% |
| Q1 2023 | 113.00M | -1.74% |
| Q4 2022 | 115.00M | -2.54% |
| Q3 2022 | 118.00M | -0.84% |
| Q2 2022 | 119.00M | -1.65% |
| Q1 2022 | 121.00M | -3.20% |
| Q4 2021 | 125.00M | +0.00% |
| Q3 2021 | 125.00M | -1.57% |
| Q2 2021 | 127.00M | -5.93% |
| Q1 2021 | 135.00M | -1.46% |
| Q4 2020 | 137.00M | +0.00% |
| Q3 2020 | 137.00M | +0.74% |
| Q2 2020 | 136.00M | +0.74% |
| Q1 2020 | 135.00M | -0.74% |
| Q4 2019 | 136.00M | -0.73% |
| Q3 2019 | 137.00M | +0.74% |
| Q2 2019 | 136.00M | +0.00% |
| Q1 2019 | 136.00M | -0.73% |
| Q4 2018 | 137.00M | -1.44% |
| Q3 2018 | 139.00M | +0.00% |
| Q2 2018 | 139.00M | +0.00% |
| Q1 2018 | 139.00M | +0.00% |
| Q4 2017 | 139.00M | -0.71% |
| Q3 2017 | 140.00M | +0.00% |
| Q2 2017 | 140.00M | -0.71% |
| Q1 2017 | 141.00M | +0.00% |
| Q4 2016 | 141.00M | -0.70% |
| Q3 2016 | 142.00M | +0.00% |
| Q2 2016 | 142.00M | -1.39% |
| Q1 2016 | 144.00M | +0.00% |
| Q4 2015 | 144.00M | -0.69% |
| Q3 2015 | 145.00M | +0.00% |
| Q2 2015 | 145.00M | -0.68% |
| Q1 2015 | 146.00M | +0.00% |
| Q4 2014 | 146.00M | +0.69% |
| Q3 2014 | 145.00M | +0.00% |
| Q2 2014 | 145.00M | +0.00% |
| Q1 2014 | 145.00M | -0.68% |
| Q4 2013 | 146.00M | -3.25% |
| Q3 2013 | 150.90M | -2.08% |
| Q2 2013 | 154.10M | -3.32% |
| Q1 2013 | 159.40M | -0.44% |
| Q4 2012 | 160.10M | -0.37% |
| Q3 2012 | 160.70M | +0.56% |
| Q2 2012 | 159.80M | +0.06% |
| Q1 2012 | 159.70M | +0.88% |
| Q4 2011 | 158.30M | -0.44% |
| Q3 2011 | 159.00M | -0.25% |
| Q2 2011 | 159.40M | -2.33% |
| Q1 2011 | 163.20M | +1.05% |
| Q4 2010 | 161.50M | -7.34% |
| Q3 2010 | 174.30M | -3.60% |
| Q2 2010 | 180.80M | -0.88% |
| Q1 2010 | 182.40M | +1.22% |
| Q4 2009 | 180.20M | -3.74% |
| Q3 2009 | 187.20M | +0.11% |
| Q2 2009 | 187.00M | -1.94% |
| Q1 2009 | 190.70M | +0.70% |
| Q4 2008 | 189.37M | -3.97% |
| Q3 2008 | 197.19M | +0.55% |
| Q2 2008 | 196.12M | +0.17% |
| Q1 2008 | 195.78M | +0.84% |
| Q4 2007 | 194.14M | -0.74% |
| Q3 2007 | 195.59M | +0.57% |
| Q2 2007 | 194.48M | -0.40% |
| Q1 2007 | 195.26M | +0.97% |
| Q4 2006 | 193.38M | -3.37% |
| Q3 2006 | 200.13M | -0.23% |
| Q2 2006 | 200.59M | -0.22% |
| Q1 2006 | 201.03M | +1.33% |
| Q4 2005 | 198.40M | -3.75% |
| Q3 2005 | 206.13M | -0.21% |
| Q2 2005 | 206.55M | +0.20% |
| Q1 2005 | 206.14M | +2.19% |
| Q4 2004 | 201.72M | -2.34% |
| Q3 2004 | 206.54M | -2.02% |
| Q2 2004 | 210.79M | -2.95% |
| Q1 2004 | 217.20M | +5.29% |
| Q4 2003 | 206.28M | -3.86% |
| Q3 2003 | 214.56M | -0.37% |
| Q2 2003 | 215.35M | +5.10% |
| Q1 2003 | 204.91M | +2.42% |
| Q4 2002 | 200.07M | +0.33% |
| Q3 2002 | 199.42M | -0.58% |
| Q2 2002 | 200.59M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Shares Outstanding Formula & Definition
Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shares Outstanding FAQ
- What is the shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The shares outstanding for DGX stock is 112.00M.
- What is the TTM average shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The TTM average shares outstanding for DGX stock is 112.60M.
- What is the 3Y average shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The 3Y average shares outstanding for DGX stock is 112.85M.
- What is the 5Y average shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The 5Y average shares outstanding for DGX stock is 115.85M.
- What is the 10Y average shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The 10Y average shares outstanding for DGX stock is 127.44M.
- What is the 15Y average shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The 15Y average shares outstanding for DGX stock is 135.68M.
- What is the 20Y average shares outstanding for Quest Diagnostics Incorporated (DGX)?
- The 20Y average shares outstanding for DGX stock is 149.06M.
DGX Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2026-03-31 | 112.00M |
| 2025-12-31 | 112.00M |
| 2025-09-30 | 113.00M |
| 2025-06-30 | 113.00M |
| 2025-03-31 | 113.00M |
| 2024-12-31 | 113.00M |
| 2024-09-30 | 113.00M |
| 2024-06-30 | 112.00M |
| 2024-03-31 | 112.00M |
| 2023-12-31 | 113.00M |
| 2023-09-30 | 114.00M |
| 2023-06-30 | 114.00M |
| 2023-03-31 | 113.00M |
| 2022-12-31 | 115.00M |
| 2022-09-30 | 118.00M |
| 2022-06-30 | 119.00M |
| 2022-03-31 | 121.00M |
| 2021-12-31 | 125.00M |
| 2021-09-30 | 125.00M |
| 2021-06-30 | 127.00M |
| 2021-03-31 | 135.00M |
| 2020-12-31 | 137.00M |
| 2020-09-30 | 137.00M |
| 2020-06-30 | 136.00M |
| 2020-03-31 | 135.00M |
| 2019-12-31 | 136.00M |
| 2019-09-30 | 137.00M |
| 2019-06-30 | 136.00M |
| 2019-03-31 | 136.00M |
| 2018-12-31 | 137.00M |
| 2018-09-30 | 139.00M |
| 2018-06-30 | 139.00M |
| 2018-03-31 | 139.00M |
| 2017-12-31 | 139.00M |
| 2017-09-30 | 140.00M |
| 2017-06-30 | 140.00M |
| 2017-03-31 | 141.00M |
| 2016-12-31 | 141.00M |
| 2016-09-30 | 142.00M |
| 2016-06-30 | 142.00M |
| 2016-03-31 | 144.00M |
| 2015-12-31 | 144.00M |
| 2015-09-30 | 145.00M |
| 2015-06-30 | 145.00M |
| 2015-03-31 | 146.00M |
| 2014-12-31 | 146.00M |
| 2014-09-30 | 145.00M |
| 2014-06-30 | 145.00M |
| 2014-03-31 | 145.00M |
| 2013-12-31 | 146.00M |
| 2013-09-30 | 150.90M |
| 2013-06-30 | 154.10M |
| 2013-03-31 | 159.40M |
| 2012-12-31 | 160.10M |
| 2012-09-30 | 160.70M |
| 2012-06-30 | 159.80M |
| 2012-03-31 | 159.70M |
| 2011-12-31 | 158.30M |
| 2011-09-30 | 159.00M |
| 2011-06-30 | 159.40M |
| 2011-03-31 | 163.20M |
| 2010-12-31 | 161.50M |
| 2010-09-30 | 174.30M |
| 2010-06-30 | 180.80M |
| 2010-03-31 | 182.40M |
| 2009-12-31 | 180.20M |
| 2009-09-30 | 187.20M |
| 2009-06-30 | 187.00M |
| 2009-03-31 | 190.70M |
| 2008-12-31 | 189.37M |
| 2008-09-30 | 197.19M |
| 2008-06-30 | 196.12M |
| 2008-03-31 | 195.78M |
| 2007-12-31 | 194.14M |
| 2007-09-30 | 195.59M |
| 2007-06-30 | 194.48M |
| 2007-03-31 | 195.26M |
| 2006-12-31 | 193.38M |
| 2006-09-30 | 200.13M |
| 2006-06-30 | 200.59M |
| 2006-03-31 | 201.03M |
| 2005-12-31 | 198.40M |
| 2005-09-30 | 206.13M |
| 2005-06-30 | 206.55M |
| 2005-03-31 | 206.14M |
| 2004-12-31 | 201.72M |
| 2004-09-30 | 206.54M |
| 2004-06-30 | 210.79M |
| 2004-03-31 | 217.20M |
| 2003-12-31 | 206.28M |
| 2003-09-30 | 214.56M |
| 2003-06-30 | 215.35M |
| 2003-03-31 | 204.91M |
| 2002-12-31 | 200.07M |
| 2002-09-30 | 199.42M |
| 2002-06-30 | 200.59M |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis